These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23707151)

  • 1. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.
    Fenton PA; Hurkmans C; Gulyban A; van der Leer J; Matzinger O; Poortmans P; Collette L; Bolla M
    Radiother Oncol; 2013 Jun; 107(3):346-51. PubMed ID: 23707151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
    Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.
    Poortmans P; Bossi A; Vandeputte K; Bosset M; Miralbell R; Maingon P; Boehmer D; Budiharto T; Symon Z; van den Bergh AC; Scrase C; Van Poppel H; Bolla M;
    Radiother Oncol; 2007 Aug; 84(2):121-7. PubMed ID: 17706307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of volume segmentation in radiotherapy of adolescents; a treatment planning study by the Swedish Workgroup for Paediatric Radiotherapy.
    Kristensen I; Agrup M; Bergström P; Engellau J; Haugen H; Martinsson U; Nilsson K; Taheri-Kadkhoda Z; Lindh J; Nilsson P
    Acta Oncol; 2014 Jan; 53(1):126-33. PubMed ID: 23577745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
    Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
    Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.
    Fairchild A; Aird E; Fenton PA; Gregoire V; Gulyban A; Lacombe D; Matzinger O; Poortmans P; Ruyskart P; Weber DC; Hurkmans CW
    Radiother Oncol; 2012 Jun; 103(3):279-86. PubMed ID: 22633815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run.
    Dusserre A; Garavaglia G; Giraud JY; Bolla M
    Radiother Oncol; 1995 Sep; 36(3):229-34. PubMed ID: 8532911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate radiotherapy clinical trial quality assurance: how real should real time review be? (A TROG-OCOG Intergroup Project).
    Martin J; Frantzis J; Chung P; Langah I; Crain M; Cornes D; Plank A; Finch T; Jones M; Khoo E; Catton C
    Radiother Oncol; 2013 Jun; 107(3):333-8. PubMed ID: 23751377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in the EORTC randomized trial 22922/10925 investigating the role of irradiation of the internal mammary and medial supraclavicular lymph node chain works.
    Poortmans P; Kouloulias V; van Tienhoven G; Collette L; Struikmans H; Venselaar JL; Van den Bogaert W; Davis JB; Lambin P;
    Strahlenther Onkol; 2006 Oct; 182(10):576-82. PubMed ID: 17013570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting.
    Weber DC; Poortmans PM; Hurkmans CW; Aird E; Gulyban A; Fairchild A
    Radiother Oncol; 2011 Jul; 100(1):150-6. PubMed ID: 21722980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise.
    Cloak K; Jameson MG; Paneghel A; Wiltshire K; Kneebone A; Pearse M; Sidhom M; Tang C; Fraser-Browne C; Holloway LC; Haworth A
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):390-398. PubMed ID: 30950223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
    Purdy JA; Harms WB; Michalski J; Bosch WR
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
    Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results.
    Lambrecht M; Clementel E; Sonke JJ; Nestle U; Adebahr S; Guckenberger M; Andratschke N; Weber DC; Verheij M; Hurkmans CW
    Radiother Oncol; 2019 Mar; 132():63-69. PubMed ID: 30825971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.
    Versteijne E; Lens E; van der Horst A; Bel A; Visser J; Punt CJA; Suker M; van Eijck CHJ; van Tienhoven G
    Strahlenther Onkol; 2017 Aug; 193(8):630-638. PubMed ID: 28608305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run.
    Davis JB; Reiner B; Dusserre A; Giraud JY; Bolla M;
    Radiother Oncol; 2002 Jul; 64(1):65-73. PubMed ID: 12208577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.